TERENCE RYAN E 4

4 · iBio, Inc. · Filed May 13, 2019

Form 4

Period: 2019-02-20

Chief Scientific Officer

Transactions

Disposition to Issuer
Stock Option (right to buy)
2019-02-20−10,000→ 22,500 total
Exercise: $13.80Exp: 2020-07-14→ Common Stock (10,000 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−10,000→ 22,500 total
Exercise: $19.60Exp: 2021-10-21→ Common Stock (10,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+7,500→ 22,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (7,500 underlying)
Disposition to Issuer
Stock Option (right to buy)
2019-02-20−10,000→ 22,500 total
Exercise: $17.20Exp: 2025-09-04→ Common Stock (10,000 underlying)
Award
Stock Option (right to buy)
2019-02-20+7,500→ 22,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (7,500 underlying)
Award
Stock Option (right to buy)
2019-02-20+7,500→ 22,500 total
Exercise: $0.93Exp: 2024-02-20→ Common Stock (7,500 underlying)

Footnotes (5)

[F1]Vested in three equal annual instalments on the anniversary of the date of grant.
[F2]Fully vests on first anniversary of grant date.
[F3]Reflects number of securities beneficially owned following all transactions reported on this Form 4.
[F4]On 2/20/19, the issuer canceled, pursuant to the issuer's option exchange program, old stock options in exchange for new stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including the cancelation of this option grant to the reporting person in exchange for new options.
[F5]On 2/20/19, the issuer issued new stock options, pursuant to the issuer's option exchange program, in exchange for old stock options, on the basis of three new options in exchange for four old options, for all eligible option holders who elected to participate in the option exchange, including this option grant to the reporting person.

Documents

1 file